Plasma somatomedin activity in an infant with Beckwith Wiedemann syndrome

Early Human Development
|February 1, 1978
PubMed

Insights

Elevated somatomedin activity and growth hormone levels in an infant with Beckwith-Wiedemann syndrome may contribute to excessive fetal growth. These levels normalized by 8 months, with growth parameters also returning to normal ranges.

Area of Science:

  • Pediatric Endocrinology
  • Genetics and Developmental Biology

Background:

  • Beckwith-Wiedemann syndrome is associated with overgrowth.
  • The role of specific growth factors in fetal overgrowth is not fully understood.

Observation:

  • A neonate diagnosed with Beckwith-Wiedemann syndrome exhibited significantly elevated birth weight and length, exceeding the 97th percentile.
  • Plasma samples at birth revealed high levels of both growth hormone and somatomedin activity compared to control groups.

Findings:

  • At 8 months of age, the child's growth hormone and somatomedin activity normalized, with weight and length falling to the 75th percentile.
  • The initial elevated somatomedin activity correlated with the excessive fetal growth observed.

Implications:

  • High somatomedin activity is a potential contributor to the characteristic overgrowth in Beckwith-Wiedemann syndrome.
  • Monitoring hormonal levels in infancy may provide insights into growth patterns and potential interventions.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...